Medication Safety

Using generic liposomal amphotericin B

13 September 2024

Investigating suspected tampering with medicines

11 June 2024

Guidance on Handling of Injectable Cytotoxic Drugs in Clinical Areas in in NHS Hospitals in the UK (Yellow Cover) Edition 1 July 2018

31 July 2018Intended audience: This document is intended as a reference and source of information to the following audiences: Nursing staff who handle cytotoxic chemotherapy (Oncology /…

Managing risks of betamethasone soluble tablets used as mouthwash

9 July 2021Serious side effects can be caused if betamethasone soluble tablets used as mouthwash are swallowed. Providing clear patient directions can help prevent harm

Safe practice for handling multiple COVID-19 vaccines

2 March 2021A number of COVID-19 vaccines are available, all with different handling and dosing requirements; sites need to plan to reduce the risk of errors

The Medication Safety Officer (MSO) role

15 December 2022Understanding the role and responsibilities of the MSO in practice will assist organisations in delivering their medication safety agenda

Learning from medication incidents and harms

15 December 2022Practical guidance to ensure opportunities to learn from local intelligence, including patient harm are translated into shared local and national learning

Medication safety across the system: opioid safety

29 March 2023Discussion of key current medication safety challenges within healthcare with a focus on opioids. We aim to inspire partnership working across the system.

Promoting medication incident reporting

15 December 2022Increased medication incident reporting provides greater opportunities for learning and improving medication safety

Reporting and management of medication incidents and harms

15 December 2022High quality reporting and management of incidents and harms ensures opportunities for learning and improving medication safety

SPS - Specialist Pharmacy Service

NHS